Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Thursday and the first part of Friday kind of went well for some of the shares I have discussed on these pages. Randgold Resources (RRS) proved again why it is really the only larger cap gold company to worry about. Rising production? Tick. Cash costs below US$700/ounce? Tick. Ungeared balance sheet? Tick. High reserve grade and exploration potential? Tick. It is good to see the shares back above the £40 level again – and I think they have much further to go. Gold shares are horribly out-of-favour but when you have a company with the above attributes and who only build and develop mines from the perspective of US$1000/ounce gold you have a buffer. Good news too that ebola has had no impact in the areas of Africa they are mining in. Buy any dip.
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.